Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Recommendations for introducing genetics services in developing countries

Abstract

Many concerned scientists believe that developments in the medical application of genomics will widen the gap between the developed and the developing world. We argue that most developing countries now urgently need to incorporate genetic approaches (including DNA diagnosis) into their health services, and that many are able to do so. DNA diagnosis is relatively inexpensive, helps to develop skills in molecular biology and provides a basis for developing national expertise in genomics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Estimated average prevalence of congenital and genetic disorders by WHO region.
Figure 2: Age distribution of the populations of a typical high-resource country (United Kingdom) and a typical lower-resource country (Iran).
Figure 3: The 'global development curve'.

Similar content being viewed by others

References

  1. Advisory Committee on Health Research. Genomics and World Health (World Health Organization, Geneva, 2002).

  2. Bloom, B. R. & Trach, D. D. Genetics and developing countries. BMJ 322, 1006–1007 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. The World Bank. World Development Indicators 1999 [online] (cited 26/11/02) <http://www.worldbank.org> (1999).

  4. Rimoin, D. L., Connor, J. M., Peyeritz, R. E. & Korf, B. R. (eds) Principles and Practice of Medical Genetics, 4th edn (Churchill Livingstone, London, 2002).

    Google Scholar 

  5. Berwick, D. “We all have AIDS”: case for reducing the cost of HIV drugs to zero. BMJ 324, 214–216 (2002).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Childs, B. & Scriver, C. R. Age at onset and causes of disease. Perspect. Biol. Med. 29, 437–460 (1985).

    Article  Google Scholar 

  7. Czeizel, A. & Sankaranarayanan, K. The load of genetic and partly genetic disorders in man. I. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life. Mutat. Res. 128, 73–103 (1984).

    Article  CAS  PubMed  Google Scholar 

  8. Baird, P. A., Anderson, T. W., Newcombe, H. B. & Lowry, R. B. Genetic disorders in children and young adults: a population study. Am. J. Hum. Genet. 42, 677–693 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. WHO Advisory Group on Hereditary Diseases. Community Approaches to the Control of Hereditary Diseases [online] <http://whqlibdoc.who.int/hq/1985-86/HDP_WG_85.10.pdf> (1985).

  10. Alwan, A. A. & Modell, B. Community Control of Genetic and Congenital Disorders. EMRO Technical Publications Series 24 (World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, 1997).

    Google Scholar 

  11. World Health Organization. Guidelines for Control of Haemoglobin Disorders WHO/HDP/HB/GL/94.1 (WHO, Geneva, 1994).

  12. World Health Organization. Glucose-6-phosphate dehydrogenase deficiency. Report of a WHO Working Group. Document HDP/WP/G6PD/85.9 (WHO, Geneva, 1985).

  13. Bittles, A. H. Consanguineous Marriage: Current Global Incidence and its Relevance to Demographic Research (Population Studies Center, University of Michigan, 1990).

    Google Scholar 

  14. United Nations. Demographic Yearbook Series (United Nations/Nations Unies, New York, 1981 and 1999 (figure 3), and 1999 (calculations in figure 1 and table 1).

  15. World Health Organization. Primary Health Care Approaches for the Prevention and Control of Congenital and Genetic Disorders WHO Meeting Report, Cairo, Egypt, 6–8 December 1999, WHO/HGN/WG/00.1 (WHO, Geneva, 2000).

  16. Christianson, A. L. Down syndrome in sub Saharan Africa. J. Med. Genet. 33, 89–92 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Czeizel, A., Intody, Z. & Modell, B. What proportion of congenital anomalies can be prevented? BMJ 306, 499–502 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. World Health Organization. The Global Strategy for the Prevention and Control of Noncommunicable Diseases — Report of the Director General (Report from the 53rd World Health Assembly, Geneva, 2000).

  19. Alwan, A., Maclean, D. & Mandil, A. Assessment of National Capacity for Noncommunicable Disease Prevention and Control: The Report of a Global Survey (World Health Organization, Geneva, 2001).

  20. Department of Health. Report on Health and Social Subjects. 50. Folic Acid and the Prevention of Disease: Report of Committee on Medical Aspects of Food and Nutrition Policy (DoH, London, UK, 2000).

  21. Czeizel, A. E. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am. J. Med. Genet. 62, 179–183 (1996).

    Article  CAS  PubMed  Google Scholar 

  22. Barker, D. J. P. (ed.) Fetal and Infant Origins of Adult Disease (British Medical Journal, London, 1993)

    Google Scholar 

  23. World Health Organization. Reducing Risks, Promoting Healthy Life (WHO, Geneva, 2002).

  24. Chitty, L. in Fetal Medicine. Basic Science and Clinical Practice (eds Rodeck, C. H. & Whittle, M. J.) 389–408 (Churchill Livingstone, London, 1999).

    Google Scholar 

  25. Murray, J., Cuckle, H., Taylor, G., Littlewood, J. & Hewison, J. Screening for Cystic Fibrosis. Health Technology Assessment Vol. 3, No. 8 [online] <http://www.hta.nhsweb.nhs.uk> (1999).

    Google Scholar 

  26. Seymour, C. A. et al. Newborn Screening for Inborn Errors of Metabolism: A Systematic Review. Health Technology Assessment Vol. 1, No. 11 [online] <http://www.hta.nhsweb.nhs.uk> (1997).

    Google Scholar 

  27. Declaration of Alma-Ata. International Conference on Primary Health Care, Alma-Ata, USSR, 6–12 September 1978 [online] <http://www.who.int/hpr/archive/docs/almaata.html> (1978).

  28. Petrou, M. & Modell, B. Prenatal screening for haemoglobin disorders. Prenat. Diagn. 15, 1275–1295 (1995).

    Article  CAS  PubMed  Google Scholar 

  29. Modell, B., Darlison, M., Khan, M. & Harris, R. Role of genetic diagnosis registers in ongoing consultation with the community. Commun. Genet. 3, 144–147 (2001).

    Google Scholar 

  30. World Health Organization. Health InterNetwork Access to Research Initiative (HINARI) [online] <http://www.healthinternetwork.org> (1986).

  31. SciDevNet. [online] <http://www.scidev.net> (2002).

  32. Modell, B. & Darlison, M. New developments in genetics for the new millennium: the concept of clinical bioinformatics. Commun. Genet. 3, 184–189 (2001).

    Google Scholar 

  33. Orphanet. [online] <http://orphanet.infobiogen.fr> (2002).

  34. World Health Organization. Services for the Prevention and Management of Genetic Disorders and Birth Defects in Developing Countries (WHO, Geneva, 1999).

  35. Penchaszadeh, V. in Genetics and Public Health in the 21st Century (eds Khoury, M. J., Burke, W. & Thomson, E. J.) 301–327 (Oxford Univ. Press, New York, 2000).

    Book  Google Scholar 

  36. Ahmed, S., Saleem, M., Modell, B. & Petrou, M. Extended family studies: a cost effective approach for genetic counseling for hemoglobin disorders in Pakistan. N. Engl. J. Med. 347, 1162–1168 (1991).

    Article  Google Scholar 

  37. Bundey, S. & Aslam, H. A five-year prospective study of the health of children in different ethnic groups, with particular reference to the effect of inbreeding. Eur. J. Hum. Genet. 1, 206–219 (1993).

    Article  CAS  PubMed  Google Scholar 

  38. Modell, B. & Darr, A. Genetic counselling and customary consanguineous marriage. Nature Rev. Genet. 3, 225–229 (2002).

    Article  CAS  PubMed  Google Scholar 

  39. Modell, B., Kuliev, A. M. & Wagner, M. Community Genetics Services in Europe European Series No. 38 (WHO Regional Publications, Copenhagen, 1991).

    Google Scholar 

  40. Titmuss, R. M. The Gift Relationship; From Human Blood to Social Policy Updated edn (eds Oakley, A. & Ashton, J.) (London School of Economics and Political Science, London, 1997).

    Book  Google Scholar 

  41. Angastiniotis, M. A., Kyriakidou, S. & Hadjiminas, M. How thalassaemia was controlled in Cyprus. World Health Forum 7, 291–297 (1986).

    Google Scholar 

  42. Kuliev, A. M. Thalassaemia can be prevented. World Health Forum 7, 286–290 (1986).

    Google Scholar 

  43. World Health Organization. Haemoglobin Disorders as a Model for Integrating Genetics into Health Care, Report of a WHO Meeting, Athens, Greece, 18 October 2001, Annex 4.2, The Tunisian Experience (WHO, Geneva, 2002).

  44. Zeuner, D. et al. Antenatal and Neonatal Haemoglobinopathy Screening in the UK: Review and Economic Analysis NHS R&D HTA Programme [online] <http://www.hta.nhsweb.nhs.uk> (1999).

    Google Scholar 

  45. Luzzatto, L. & Mehta, A. in The Metabolic Basis of Inherited Disease 7th edn Vol. 3 (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) 3367–3398 (McGraw–Hill, Inc., New York, 1995).

    Google Scholar 

  46. Karnon, J. et al. Lifetime treatment costs of β-thalassaemia major. Clin. Lab. Haematol. 21, 377–385 (1999).

    Article  CAS  PubMed  Google Scholar 

  47. Liu, J. Studies of β-thalassemia mutations and prenatal diagnosis in Guangxi, Guangdong and Sichuan Provinces of South China. Zhongguo-Yi-Xue-Ke-Xue-Yuan-Xue-Bao 12, 90–95 (1990) (in Chinese).

    CAS  PubMed  Google Scholar 

  48. Chan, T. K. et al. Prenatal diagnosis of α- and β-thalassemias: experience in Hong Kong. Hemoglobin 12, 787–794 (1988).

    Article  CAS  PubMed  Google Scholar 

  49. Thakur-Mahadik, C. et al. Prenatal diagnosis of β-thalassaemia and other haemoglobinopathies in India. Prenat. Diagn. 20, 194–201 (2000).

    Article  CAS  PubMed  Google Scholar 

  50. Setianingsih, I. et al. Phenotypic variability of Filipino β(0)-thalassemia/HbE patients in Indonesia. Am. J. Hematol. 62, 7–12 (1999).

    Article  CAS  PubMed  Google Scholar 

  51. George, E. et al. Spectrum of β-thalassaemia mutations in transfusion dependent thalassaemia patients: practical implications in prenatal diagnosis. Med. J. Malaysia 48, 325–329 (1993).

    CAS  PubMed  Google Scholar 

  52. Chern, S. R. & Chen, C. P. Molecular prenatal diagnosis of thalassemia in Taiwan. Int. J. Gynaecol. Obstet. 69, 103–106 (2000).

    Article  CAS  PubMed  Google Scholar 

  53. Fucharoen, S. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: experience from 100 pregnancies. SE Asian J. Trop. Med. Public Health 22, 16–29 (1991).

    CAS  Google Scholar 

  54. Altay, C., Yilgor, E., Beksac, S. & Gurgey, A. Premarital screening of hemoglobinopathies: a pilot study in Turkey. Hum. Hered. 46, 112–114 (1996).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

B.M. is a retired Wellcome Principal Research Fellow.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernadette Modell.

Related links

Related links

DATABASES

OMIM

congenital hypothyroidism

cystic fibrosis

Down syndrome

factor V Leiden

G6PD deficiency

haemochromatosis

haemophilia

phenylketonuria

sickle cell disorder

Tay–Sachs disease

thalassaemias

FURTHER INFORMATION

Accessible Publishing of Genetic Information (APoGI) on haemoglobin disorders

Epidemiological information on consanguineous marriage

Information on rare diseases (including many inherited disorders) in six languages

SciDevNet (news, views, and information about science and development)

The Health InterNetwork Access to Research Initiative (HINARI)

The World Bank

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alwan, A., Modell, B. Recommendations for introducing genetics services in developing countries. Nat Rev Genet 4, 61–68 (2003). https://doi.org/10.1038/nrg978

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrg978

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing